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The data explained  244 doctors and the problem of comparing mortality rates
Figures on mortality rates
are collected and analysed in
various ways by different
heart units in hospital trusts
around the country, making
it impossible to compare
individual heart surgeons.
Under the Guardian’s
request for information, all
units were able to give “raw”
mortality data for surgeons
who do bypass operations —
number of cases, and number
and percentage of those
dying. But those figures tell
very little. Sometimes the
best surgeons have the
Following the example of
four trusts in the north-west
who published their results
in the British Medical
Journal, we asked heart units
to split cases into low risk of
five points or fewer, and high
risk of six or more. 
Surgeons disagree, some-
times strongly, over how best
to assess risk and therefore
how to present death rates.
Some say the north-west
trusts have not risk-adjusted,
but only risk-stratified,
which does not allow for the
complexity of some high risk
cases. Papworth and St
George’s in London are
among those who prefer
logistic EuroSCORE, which
gives a more complex
computer value for each risk
factor. 
Other units use the older
Parsonnet system, which also
gives a value for each factor,
but is now generally thought
to over-estimate chances of a
death, which some think
make a surgeon’s results look
better than with EuroSCORE.
The data on this page are
split in five groups: high/low
including pre- and post-
operative care and
anaesthesia. All hospitals
investigate deaths in surgery
to see how the whole team
can learn. 
We checked all the figures
with the trusts which
supplied them, and invited
comments from the
individual surgeons. Many
emphasised the care that
must be taken in drawing
conclusions. 
Some had specific points,
arguing that other markers
such as morbidity during
surgery (for instance, brain
damage) could be better
indicators. 
Some were concerned
publication could lead to
risk-averse behaviour, with
surgeons avoiding more
complicated cases. Some
disputed data their trust
supplied for them. 
Others said they would
have liked longer to peruse
the paperwork themselves
and check. 
Some of their individual
comments will be found on
the Guardian website.
bypasses in emergencies. Few
deaths in few operations
gives a worse mortality rate
than few deaths in many
operations.
On a graph using 95%
confidence intervals, which
allows for all of this, each
surgeon is within the
acceptable limits laid down
by the Society of
Cardiothoracic Surgeons.
Although the surgeon
operating or supervising the
operation is responsible for
its outcome, a death can be
due to many factors,
Risk adjusted data (EuroSCORE)
Total Low risk High risk
Hospital Surgeon Cases Deaths % Cases Deaths % Cases Deaths %
Blackpool Victoria Hospital Au 425 5 1.2 349 1 0.3 76 4 5.3
Duncan 448 2 0.4 379 1 0.3 69 1 1.4
Millner 503 11 2.2 419 5 1.2 84 6 7.1
Sogliani** 280 1 0.4 229 1 0.4 51 0 0
Brighton & Sussex University Hospitals Cohen 140 4 2.9 120 1 0.8 20 3 15
Forsyth 461 17 3.7 381 8 2.1 80 9 11.3
Hyde 389 7 1.8 338 2 0.6 51 5 9.8
Trivedi 359 4 1.1 306 2 0.7 53 2 3.8
Cardiothoracic Centre Liverpool Chalmers 527 13 2.5 415 5 1.2 112 8 7.1
Dihmis 567 8 1.4 469 4 0.9 98 4 4.1
Fabri 308 8 2.6 252 6 2.4 56 2 3.6
Griffiths 293 11 3.8 230 3 1.3 63 8 12.7
Mediratta 488 8 1.6 412 4 1 76 4 5.3
Oo 197 7 3.6 149 2 1.3 48 5 10.4
Pullan 513 8 1.6 406 3 0.7 107 5 4.7
Rashid 371 9 2.4 290 5 1.7 81 4 4.9
Castle Hill Hospital Cale 508 7 1.4 437 2 0.5 71 5 7
Guvendik 529 8 1.5 478 4 0.8 51 4 7.8
Cowen 328 7 2.1 262 3 1.2 66 4 6.1
Griffin 607 7 1.2 456 1 0.2 151 6 4
Coventry and Warwickshire Trust Bhabra† 86 2 2.3 66 1 1.5 20 1 5
Briffa ≥ 264 9 3.4 209 4 1.9 55 5 9.1
Dimitri 352 8 2.3 297 3 1 55 5 9.1
Norton 321 3 0.9 264 0 0 57 3 5.3
Patel 231 2 0.9 171 0 0 60 2 3.3
Rosin 282 5 1.8 232 2 0.9 50 3 6
Guy’s and St. Thomas’ Hospital Anderson** 235 5 2.1 214 4 1.9 21 1 4.8
Austin 276 3 1.1 242 3 1.2 34 0 0
Blauth 292 8 2.7 202 2 1 90 6 6.7
O’Riordan 519 6 1.2 433 4 0.9 86 2 2.3
Roxburgh 349 6 1.7 279 4 1.4 70 2 2.9
Shabbo 416 9 2.2 334 5 1.5 82 4 4.9
Venn 235 1 0.4 153 0 0 82 1 1.2
Young 228 2 0.9 175 1 0.6 53 1 0.9
John Radcliffe Armistead 271 5 1.8 206 2 1 65 3 4.6
Pillai 192 9 4.7 142 2 1.4 50 7 14
Ratnatunga 342 17 5 229 4 1.7 113 13 11.5
Taggart 340 12 3.5 262 4 1.5 78 8 10.3
Westaby 112 3 2.7 81 2 2.5 31 1 3.2
MRI Manchester Heart Centre Grotte 362 7 1.9 311 5 1.6 51 2 3.9
Hasan** 413 2 0.5 349 1 0.3 64 1 1.6
Keenan 328 6 1.8 275 3 1.1 53 3 5.7
McLaughlin 41 0 0 36 0 0 5 0 0
Odom 337 9 2.7 286 5 1.7 51 4 7.8
Prendergast 438 14 3.2 375 7 1.9 63 7 11.1
Plymouth Hospitals Trust Allen 523 6 1.1 440 3 0.7 83 3 3.6
Dalrymple-Hay 401 9 2.2 315 3 1 86 6 7
Kuo 202 3 1.5 160 1 0.6 42 2 4.8
Lewis 141 2 1.4 108 1 0.9 33 1 3
Marchbank 487 8 1.6 342 2 0.6 145 6 4.1
Unsworth-White 397 6 1.5 298 2 0.7 99 4 4
Royal Victoria Hospital Graham**†ƒ 144 4 2.8 112 0 0 32 4 12.5
Total Low risk High risk
Hospital Surgeon Cases Deaths % Cases Deaths % Cases Deaths %
St Mary’s Hospital Casula**ƒ 437 10 2.3 215 2 0.9 86 5 5.8
Stanbridgeƒ 449 9 2 187 1 0.5 73 4 5
South Manchester Universities Bridgewater 258 3 1.2 223 2 0.9 35 1 2.9
Campbell 290 5 1.7 248 2 0.8 42 3 7.1
Carey 400 9 2.2 347 3 0.9 53 6 11.3
Hooper 266 1 0.4 247 1 0.4 19 0 0
Jones 239 3 1.3 191 1 0.5 48 2 4.2
Waterworth 386 6 1.6 330 4 1.2 56 2 3.6
Yonan 388 3 0.8 323 2 0.6 65 1 1.5
University College London Hospitals Trust Hayward 229 5 2.2 201 4 2 28 1 3.6
Kallis† 108 0 0 101 0 0 7 0 0
Keogh**† 33 1 3 26 1 3.9 7 0 0
Kolvekar 373 12 3.2 313 4 1.3 60 8 13.3
Lawrence 379 4 1.1 313 2 0.6 66 2 3
Pattison† 8 1 12.5 6 1 16.7 2 0 0
Sogliani**† 97 4 4.1 83 1 1.2 14 3 21.4
V Tsang**† 1 0 0 1 0 0 0 0 0
Van Doorn**† 0 0 0 0 0 0 0 0 0
Walesby 404 10 2.5 349 6 1.7 55 4 7.3
Yap † ≥ 206 3 1.5 177 0 0 29 3 10.3
University Hospital of Wales Amer**† 100 2 2 72 1 1.4 28 1 3.6
Azzu 358 2 0.6 280 0 0 78 2 2.6
Butchart 71 1 1.4 54 1 1.9 17 0 0
Hayat† 8 0 0 6 0 0 2 0 0
Kulatilake 217 2 0.9 179 0 0 38 2 5.3
Mehta† 90 1 1.1 63 0 0 27 1 3.7
O’Keefe 251 14 5.6 196 6 3.1 55 8 14.5
von Oppell 241 3 1.2 160 1 0.6 81 2 2.5
Zamvar**†≥ 98 2 2 77 1 1.3 21 1 4.8
University of North Staffordshire Trust Abid† 340 3 0.9 288 0 0 52 3 5.8
Levine 612 15 2.5 524 8 1.5 88 7 8
Parmar 400 6 1.5 346 5 1.4 54 1 1.9
Ridley 307 1 0.3 275 0 0 32 1 3.1
Satur† 411 5 1.2 329 3 0.9 82 2 2.4
Smallpeice 429 5 1.2 353 1 0.3 76 4 5.3
Risk adjusted data (Parsonnet)
Total Low risk High risk
Hospital Surgeon Cases Deaths % Cases Deaths % Cases Deaths %
Royal Brompton and Harefield Hospital Amrani 647 12 1.9 465 4 0.9 182 8 4.4
De Souza 660 6 0.9 440 1 0.2 220 5 2.3
Dreyfus† 199 5 2.5 129 1 0.8 70 4 5.7
Gaer 294 6 2 193 1 0.5 101 5 4.9
Khagani 359 13 3.6 257 5 1.9 102 8 7.8
Moat 428 3 0.7 291 0 0 137 3 2.2
Pepper 367 15 4.1 235 3 1.3 132 12 9.1
Petrou† 140 1 0.7 93 0 0 47 1 2.1
Sarkar**† 446 3 0.7 319 1 0.3 127 2 1.6
Tadjkarimi† 255 6 2.4 207 3 1.4 48 3 6.2
Non risk adjusted data (adjusted data on website)
Hospital Surgeon Cases Deaths %
Bristol Royal Infirmary Amer**† 105 3 2.9
Angelini 303 1 0.3
Ascione† 181 2 1.1
Bryan 392 6 1.5
Caputo† 31 0 0
Casula**† 38 1 2.6
Ciulli 456 13 2.9
Hutter 412 8 1.9
Parry† - - -
Pawade 59 1 1.7
Underwood 238 3 1.3
King’s College Hospital Bhathagar 87 2 2.3
Desai 271 7 2.6
Deshpande 96 1 1
El Gamel 259 2 0.8
Ibrahim 99 2 2
John 343 3 0.9
Marrinan 268 9 3.4
Newcastle Upon Tyne Hasan**† 55 0 0
Tocewicz† 324 3 0.9
Clark 272 4 1.5
Dark 131 7 5.3
Forty 291 9 3.1
Hamilton 94 2 2.1
Hilton 281 13 4.6
Ledingham 301 6 2
Pillay 386 9 2.3
Schueler† 213 8 3.8
St George’s Hospital Chandrasekaran 533 5 0.9
Jahangiri 575 10 1.7
Kanagasabay 424 5 1.2
Sarsam 467 9 1.9
Smith** 315 5 1.6
Hospital Surgeon Cases Deaths %
Southampton University Barlow 173 2 1.2
G Tsang** 231 0 0
Haw 139 8 5.8
Langley 170 4 2.4
Livesey 210 7 3.3
Monro 216 7 3.2
Ohri 315 6 1.9
Sunder† 11 1 9.1
Non risk adjusted data
Aberdeen Royal Infirmary 1 455 9 2
2 349 9 2.6
3 329 2 0.6
4† 103 3 2.9
5† 166 4 2.4
Barts & the London Hospitals Awad† 171 1 0.6
Bahrami**† 37 1 2.7
Edmondson 130 1 0.8
Lall† 348 4 1.1
Magee 184 2 1.1
Shipolini 395 6 1.5
Uppal 227 5 2.2
Weir 297 3 1
Wong 299 5 1.7
Wood 237 7 2.9
City Hospital Nottingham Birdi† 239 3 1.3
Mitchell 302 5 1.6
Naik 306 8 2.6
Richens 216 3 1.3
North Glasgow University Berg 431 9 2.1
Butler 414 8 1.9
Colquhoun 313 5 1.6
Craig 331 9 2.7
Danton**† 35 0 0
Faichney 305 11 3.6
Hospital Surgeon Cases Deaths %
Kirk 279 9 3.2
Lund**† 46 2 4.3
MacAurthur 238 5 2.1
Murday 336 9 2.7
Nkere 467 12 2.6
Pathi 465 7 1.5
Pollock 92 2 2.2
Wheatley 73 1 1.4
Hammersmith Hospitals Anderson** 346 6 1.8
Bahrami**† 113 5 4.4
Hornick† 14 0 0
Punjabi 399 8 2
Smith** 293 9 3.1
Taylor† 131 7 5.3
Leeds Teaching Hospital Kaul 626 5 0.8
Kay 426 6 1.4
McGoldrick 393 1 0.2
Munsch 285 11 3.9
Nair 398 1 0.2
O’Regan 528 9 1.7
Van Doorn**† 35 0 0
Watterson 174 0 0
Weerasena† 0 0 0
Lothian University Hospitals Brackenbury 313 10 3.2
Cameron† 2 0 0
Campanella 282 4 1.4
Mankad 213 2 0.9
O’Toole† 115 4 3.5
Pessotto† 94 1 1.1
Prasad 340 4 1.2
Walker 91 1 1.1
Zamvar**† 184 5 2.7
Royal Victoria Hospital Campalani† 222 7 3.1
Danton**† 93 4 4.3
Hospital Surgeon Cases Deaths %
Gladstone† 130 3 2.3
Lund**† 117 1 0.8
MacGowan† 187 4 2.1
South Tees Hospital Hunter 380 13 3.42
Kendall 577 10 1.73
Morritt 434 5 1.15
Owens† 266 1 0.38
Rao† 112 1 0.88
Wallis 470 5 1.06
St Mary’s Hospital Glenvilleƒ 415 14 3
Swansea Trust Argano 292 1 0.3
Ashraf 503 4 0.8
Youhana 471 7 1.5
Zaidi† 153 0 0
University Hospital Birmingham Bonser 237 7 3
Graham** 306 5 1.6
Keogh** 193 6 3.1
Mascaro† 75 2 2.7
Pagano 358 5 1.4
Rooney 399 4 1
Wilson 378 3 0.8
Firmin 280 4 1.4
Galinanes 307 2 0.7
Hadjinikolaou 442 1 0.2
Hickey 355 2 0.6
Leverment 149 1 0.7
Sosnowski 314 1 0.3
Spyt 308 5 1.6
Risk adjusted data (Mean EuroSCORE)
Total Confidence Ave %
Cases Deaths % Interval predicted
Papworth Dunning 224 5 2.23 0.72-5.21 3.82
Jenkins 405 7 1.73 0.69-3.56 4.87
Large 320 8 2.5 1.08-4.93 5.07
Nashef 409 3 0.73 0.15-2.14 4.33
Ritchie 502 15 2.99 1.67-4.93 6.25
Rosengard**† 44 0 0 0-8.38 3.04
Tsui 393 6 1.53 0.56-3.32 3.7
Wallwork 228 4 1.75 0.48-4.49 3.05
Wells 57 4 7.02 1.91-17.97 4.49
Risk adjusted data (Mean EuroSCORE)
Total Confidence Ave %
Cases Deaths % Interval predicted
Sheffield Billing† 50 1 2 0.1-12.0 3.7
Teaching Braidley 368 2 0.5 0.1-2.2 3.1
Cooper 306 4 1.3 0.4-3.5 3.2
Hopkinson 324 4 1.2 0.4-3.3 2.3
Kolocassides† 158 2 1.3 0.2-5.0 3.1
Matuszewski† 73 1 1.4 0.1-8.4 3.2
Sarkar**† 315 3 1 0.25-3.0 2.5
Wilkinson 263 1 0.4 0.0-2.5 2.8
Locke 325 3 0.9 0.2-2.9 2.7
risk additive EuroSCORE,
logistic EuroSCORE,
Parsonnet, no available risk-
adjusted data, and those
trusts with risk-adjusted data
on their websites or available
at the hospital which is too
complex to translate into
simple tabular form. 
A very important factor in
assessing any surgeon’s death
rates is the number of cases
he or she has done. Some
specialise in operations other
than bypass, such as mitral
valve surgery, and may do
only a few, more difficult
NOTES
† Not the full three years. 
** Surgeon worked at more than one hospital. 
ƒ Surgeons own figures  
≥ Surgeon questions whether data fully reflects caseload over three years
highest rates, because they
operate on those closest to
death and with the most to
gain from surgery.
So we requested three years
of risk-adjusted data for the
commonest operation,
coronary artery bypass graft,
asking trusts to group each
surgeon’s cases into low risk
and high risk according to a
fairly widely used system,
EuroSCORE, a check-list of a
patient’s risk factors for
surgery: age, state of his or
her heart, and so on. Each
factor scores a point.
Coronary Artery Bypass Graft
WEBSITE
www.kingsch.nhs.uk
WEBSITE
www.ubht.nhs.uk/
mainreports/
ACSAR2003-04.PDF
WEBSITE
www.newcastle-
hospitals.nhs.uk/
cardio/index.asp
WEBSITE
www.suht.nhs.uk/
index.cfm?articleid=1058
WEBSITE
www.st-georges.org.uk/
Cardiacindex.asp
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Mortality data in adult cardiac surgery for named
surgeons: retrospective examination of prospectively
collected data on coronary artery surgery and aortic valve
replacement
Ben Bridgewater on behalf of the adult cardiac surgeons of north west England
Abstract
Objectives To present named surgeon mortality for
isolated first time coronary artery surgery and aortic
valve surgery.
Design Retrospective analysis of prospectively
collected data.
Setting All NHS hospitals undertaking adult cardiac
surgery in north west England.
Participants 25 consultant surgeons carrying out
coronary artery surgery and aortic valve replacement
between April 2001 and March 2004.
Main outcome measuresMortality for both
operations according to surgeon. EuroSCORE to
stratify patients into low and high risk.
Results 10 163 patients underwent surgery under 25
surgeons. The average number of patients per
surgeon was 363 for coronary artery surge y and 44
for aortic valve replacement. Seventeen per cent of
the patients undergoing coronary artery surgery and
half of those undergoing aortic valve surgery were
considered high risk. The average mortality was 1.8%
(range 0-3.8%) for coronary surgery and 1.9%
(0-12.5%) for aortic valve surgery. Mortality for all
surgeons fell below 99% control limits of the national
mean for both operations.
Conclusions The presented mortality figures for the
two cardiac operations fell within accepted limits for
all surgeons. The division of outcomes according to
low and high risk patients is imperfect but may help
to inform the public about the complexities of
this type of analysis and prevent surgeons avoiding
high risk patents who may benefit from an
operation.
Introduction
Recent years have seen a move towards increased
openness and transparency in healthcare delivery. This
has been accelerated by a series of events, including the
Bristol Royal Infirmary inquiry into paediatric cardiac
surgery deaths.1 One recommendation of the inquiry
was that patients must be able to see information about
the relative performance of individual consultants
operating within hospitals. The Society of Cardiotho-
racic Surgeons of Great Britain and Ireland therefore
published a study in 2004 of activity and performance
of all consultants undertaking adult cardiac surgery in
the United Kingdom.2 The history leading to this
analysis and the underlying methods have been
comprehensively described.3 The study was conducted
on a single operation: first time isolated coronary
artery surgery. Because of a lack of comprehensive data
on which to perform a complete analysis that would
allow adjustments to be made for differing case mix,
the benchmarking was done on “crude” non-adjusted
mortality data. The exact mortality for individual
surgeons was not given, but instead surgeons were
listed with a comment about whether they met the
Society of Cardiothoracic Surgeons standards, which
were defined as being acceptable if the surgeon fell
within 99.99% confidence intervals of the national
average.
Janet Smith has commented that the General
Medical Council could be criticised for putting the
interests of doctors before the interests of patients.4
When it comes to publishing mortality data for
individual surgeons there is potentially a conflict
between the interests of these two groups and the con-
fidence intervals used recently by the Society of Cardio-
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Data	  preprocessing	  
•  The	  registry	  is	  cleaned:	  
–  transcripHonal,	  numerical,	  temporal	  &	  clinical	  errors	  
resolved	  
–  duplicate	  and	  non-­‐cardiac	  records	  removed	  
•  The	  data	  is	  ﬁltered:	  
–  operaHons	  between	  1st	  April	  2008	  &	  31st	  March	  2011	  
–  exclude	  transplantaHons;	  trauma;	  primary	  VADs	  
–  exclude	  minors	  (<18	  years)	  
–  exclude	  private	  hospitals	  
–  exclude	  emergency	  &	  salvage	  procedures	  
Risk-­‐adjustment	  
•  Necessary	  to	  risk-­‐
adjust	  outcome	  
measures	  
•  Old	  models,	  e.g.	  
logisHc	  EuroSCORE,	  
are	  miscalibrated	  	  
•  Would	  lead	  to	  all	  
units	  being	  idenHﬁed	  
as	  below	  the	  target	  
Logistic EuroSCORE Recalibrated EuroSCORE (08/11)
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Risk-­‐adjustment	  
•  Build	  a	  new	  model	  
–  incomplete	  data	  
–  procedure	  speciﬁc?	  
•  Reﬁt	  exisHng	  model	  
–  does	  not	  ﬁt	  
contemporary	  cohort	  
well	  
•  Recalibrate	  exisHng	  
model	  
–  only	  adjusts	  for	  single	  
variable	  
•  Other	  opHons…	  
Predicted	  mortality	  
Logistic EuroSCORE Recalibrated EuroSCORE (08/11)
0%
10%
20%
0%
3%
6%
9%
0% 10% 20% 0% 3% 6% 9%
Predicted mortality
O
bs
er
ve
d 
m
or
ta
lit
y
O
bs
er
ve
d	  
m
or
ta
lit
y	  
Goodness-­‐of-­‐ﬁt:	  Hosmer-­‐Lemeshow	  P	  =	  0.56	  
DiscriminaNon:	  AUC	  =	  0.78	  
Deﬁning	  divergence	  
•  Funnel	  plot	  methodology	  
•  Conﬁdence	  intervals	  used	  to	  classify	  ‘outliers’	  
•  For	  consultant-­‐level	  analysis	  we	  adjust	  for	  
mulHple	  comparisons	  (when	  making	  comparisons	  
of	  many	  surgeons,	  high	  probability	  of	  idenHfy	  ≥1	  
‘outlier’	  due	  to	  chance)	  
•  Standard	  errors	  are	  inﬂated	  due	  to	  observed	  
over-­‐dispersion	  (greater	  variability	  than	  expected	  
by	  the	  binomial	  model)	  
One-­‐sided	  95%	  
conﬁdence	  limit	  
adjusted	  for	  mulHple	  
comparisons	  
NaHonal	  mean	  
2.74%	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Outliers	  above	  the	  ‘target’	  categorised	  as	  yellow	  (low	  level)	  /	  
amber	  (higher	  level)	  /	  red	  (alert)	  
Two-­‐sided	  95%	  CI	  
Two-­‐sided	  99%	  CI	  
Results:	  hospitals	  
Results:	  consultants	  
Conclusions	  
•  IdenHfying	  ‘outlier’	  healthcare	  providers	  is	  
methodologically	  (and	  poliHcally)	  challenging	  
•  Combining	  clinical	  and	  analyHcal	  experHse	  can	  
reduce	  errors	  in	  classiﬁcaHon	  
•  An	  ‘outlier’	  does	  not	  necessarily	  imply	  poor	  
pracHce;	  can	  be	  amributable	  to	  data	  quality	  or	  
case	  mix	  
•  Future	  analyses	  to	  explore	  using	  more	  
sophisHcated	  staHsHcal	  methodology	  
